<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">449</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2020-19-4suppl-76-84</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>MATERIALS OF THE 3rd WORKING MEETING OF ALLERGISTS-IMMUNOLOGISTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>МАТЕРИАЛЫ III РАБОЧЕГО СОВЕЩАНИЯ АЛЛЕРГОЛОГОВ-ИММУНОЛОГОВ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Chronic nonbacterial osteomyelitis: single center experience</article-title><trans-title-group xml:lang="ru"><trans-title>Хронический небактериальный остеомиелит: опыт одного Центра</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2869-6535</contrib-id><name-alternatives><name xml:lang="en"><surname>Kozlova</surname><given-names>A. L.</given-names></name><name xml:lang="ru"><surname>Козлова</surname><given-names>А. Л.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Med. Sci., a senior researcher at the Department of Treatment Optimization for Immunodeficiencies, Department of Immunology</p><p>1 Samory Mashela St., Moscow 117997, Russia </p></bio><bio xml:lang="ru"><p>канд. мед. наук, старший научный сотрудник отдела оптимизации лечения иммунодефицита </p><p>117997, Москва, ул. Саморы Машела, 1</p></bio><email>annamax-99@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1267-9957</contrib-id><name-alternatives><name xml:lang="en"><surname>Burlakov</surname><given-names>V. I.</given-names></name><name xml:lang="ru"><surname>Бурлаков</surname><given-names>В. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4427-054X</contrib-id><name-alternatives><name xml:lang="en"><surname>Nesterenko</surname><given-names>Z. A.</given-names></name><name xml:lang="ru"><surname>Нестеренко</surname><given-names>З. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1669-8621</contrib-id><name-alternatives><name xml:lang="en"><surname>Kuzmenko</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Кузьменко</surname><given-names>Н. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8208-2075</contrib-id><name-alternatives><name xml:lang="en"><surname>Deordieva</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Деордиева</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5132-1267</contrib-id><name-alternatives><name xml:lang="en"><surname>Рoppelt</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Роппельт</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3564-6496</contrib-id><name-alternatives><name xml:lang="en"><surname>Kan</surname><given-names>N. Yu.</given-names></name><name xml:lang="ru"><surname>Кан</surname><given-names>Н. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5347-7150</contrib-id><name-alternatives><name xml:lang="en"><surname>Shvets</surname><given-names>O. A.</given-names></name><name xml:lang="ru"><surname>Швец</surname><given-names>О. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6134-3811</contrib-id><name-alternatives><name xml:lang="en"><surname>Moiseeva</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Моисеева</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0596-6088</contrib-id><name-alternatives><name xml:lang="en"><surname>Dibirova</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Дибирова</surname><given-names>С. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7684-9188</contrib-id><name-alternatives><name xml:lang="en"><surname>Horeva</surname><given-names>A. L.</given-names></name><name xml:lang="ru"><surname>Хорева</surname><given-names>А. Л.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3305-1694</contrib-id><name-alternatives><name xml:lang="en"><surname>Rodina</surname><given-names>Yu. A.</given-names></name><name xml:lang="ru"><surname>Мухина</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9857-4456</contrib-id><name-alternatives><name xml:lang="en"><surname>Muchina</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Родина</surname><given-names>Ю. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6313-6712</contrib-id><name-alternatives><name xml:lang="en"><surname>Bolshakov</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Большаков</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8129-0545</contrib-id><name-alternatives><name xml:lang="en"><surname>Shcherbakov</surname><given-names>A. P.</given-names></name><name xml:lang="ru"><surname>Щербаков</surname><given-names>А. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1918-0841</contrib-id><name-alternatives><name xml:lang="en"><surname>Remizov</surname><given-names>A. N.</given-names></name><name xml:lang="ru"><surname>Ремизов</surname><given-names>А. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7317-7104</contrib-id><name-alternatives><name xml:lang="en"><surname>Tereshchenko</surname><given-names>G. V.</given-names></name><name xml:lang="ru"><surname>Терещенко</surname><given-names>Г. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9375-7517</contrib-id><name-alternatives><name xml:lang="en"><surname>Roshchin</surname><given-names>V. Yu.</given-names></name><name xml:lang="ru"><surname>Рощин</surname><given-names>В. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7732-8184</contrib-id><name-alternatives><name xml:lang="en"><surname>Konovalov</surname><given-names>D. M.</given-names></name><name xml:lang="ru"><surname>Коновалов</surname><given-names>Д. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6158-2222</contrib-id><name-alternatives><name xml:lang="en"><surname>Likar</surname><given-names>Yu. N.</given-names></name><name xml:lang="ru"><surname>Ликарь</surname><given-names>Ю. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3113-4939</contrib-id><name-alternatives><name xml:lang="en"><surname>Shcherbina</surname><given-names>A. Yu.</given-names></name><name xml:lang="ru"><surname>Щербина</surname><given-names>А. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>1 Samory Mashela St., Moscow 117997, Russia</p></bio><bio xml:lang="ru"><p>117997, Москва, ул. Саморы Машела, 1</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Healthcare of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-01-11" publication-format="electronic"><day>11</day><month>01</month><year>2021</year></pub-date><volume>19</volume><issue>4</issue><issue-title xml:lang="en">supplement</issue-title><issue-title xml:lang="ru">приложение</issue-title><fpage>76</fpage><lpage>84</lpage><history><date date-type="received" iso-8601-date="2021-01-09"><day>09</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-01-09"><day>09</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/449">https://hemoncim.com/jour/article/view/449</self-uri><abstract xml:lang="en"><p>Chronic nonbacterial osteomyelitis (CNO) is a rare autoinflammatory disease from the group of multifactorial diseases. It is characterized by non-infectious recurrent bone lesions, usually manifesting in childhood. The aim of this study was to analyze the clinical, laboratory, radiological and histological data of 33 patients (12 boys, 21 girls) with a diagnosis of chronic nonbacterial osteomyelitis. This study is supported by the Independent Ethics Committee and approved by the Academic Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. 25/33 patients were hospitalized to the Center with suspected neoplastic disease bone. The median age of CNO manifestation was 9.6 years. 24/33 had a multi-focal form of the disease. 5 patients had fever. Nonsteroidal anti-inflammatory drugs were the first therapy for all patients, achieving clinical remission in 4 cases. Zoledronic acid were used in 29 patients with remission in 19, adalimumab in 10 patient with remission in 9. In one patient stabilization was achieved only with the combination  of methotrexate and canakinumab therapy.</p></abstract><trans-abstract xml:lang="ru"><p>Хронический небактериальный остеомиелит (ХНО) – редкое аутовоспалительное заболевание из группы мультифакториальных заболеваний. Характеризуется неинфекционным рецидивирующим поражением костной ткани, как правило, манифестирующим в детском возрасте. Целью данного исследования явилось проведение анализа клинических, лабораторных, радиологических и гистологических данных 33 пациентов (12 мальчиков, 21 девочка) с диагнозом:  хронический небактериальный остеомиелит. Исследование одобрено локальным  этическим комитетом и утверждено решением ученого совета НМИЦ ДГОИ им. Дмитрия Рогачева. В НМИЦ ДГОИ им. Дмитрия Рогачева были госпитализированы 25/33 пациентов с подозрением на течение неопластического процесса костной ткани. Медиана возраста манифестации ХНО составила 9,6 года. Мультиочаговая форма заболевания зафиксирована в 24/33 случаях. У 5 пациентов отмечались фебрильные подъемы температуры тела. Все пациенты получили терапию нестероидными противовоспалительными средствами, на фоне которой в 4/33 случаях удалось достигнуть лекарственной ремиссии, в 19/29 – ремиссия была достигнута на фоне терапии золедроновой кислотой. Десять из 29 пациентов в последующем получили антицитокиновую терапию (адалимумаб), ремиссия была достигнута в 9 случаях. У 1/10 пациента стабилизация состояния была достигнута только на комбинации терапии метотрексатом и канакинумабом.</p></trans-abstract><kwd-group xml:lang="en"><kwd>autoinflammatory syndromes</kwd><kwd>chronic nonbacterial osteomyelitis</kwd><kwd>chronic recurrent multifocal osteomyelitis</kwd><kwd>bisphosphonates</kwd><kwd>tumor necrosis factor alpha inhibitors</kwd><kwd>children</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аутовоспалительные синдромы</kwd><kwd>хронический небактериальный остеомиелит</kwd><kwd>хронический рецидивирующий мультифокальный остеомиелит</kwd><kwd>бисфосфонаты</kwd><kwd>ингибиторы фактора некроза опухоли-альфа</kwd><kwd>дети</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Wipff J., Costantino F., Lemelle I., et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumato 2015; l67: 1128–37.</mixed-citation><mixed-citation xml:lang="ru">Wipff J., Costantino F., Lemelle I., et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumato 2015; l67: 1128–37.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Stern S.M., Ferguson P.J. Autoinflammatory bone diseases. Rheum Dis Clin North Am 2013; 39: 735–49.</mixed-citation><mixed-citation xml:lang="ru">Stern S.M., Ferguson P.J. Autoinflammatory bone diseases. Rheum Dis Clin North Am 2013; 39: 735–49.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Borzutzky A., Stern S., Reiff A., Zurakowski D., Steinberg E.A.,Dedeoglu F., et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics 2012; 130: e1190–7.</mixed-citation><mixed-citation xml:lang="ru">Borzutzky A., Stern S., Reiff A., Zurakowski D., Steinberg E.A.,Dedeoglu F., et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics 2012; 130: e1190–7.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Sato H., Wada Y., Hasegawa E., Nozawa Y., Nakatsue T., Ito T., et al. Adult-onset Chronic Recurrent Multifocal Osteomyelitis with High Intensity of Muscles Detected by Magnetic Resonance Imaging, Successfully Controlled with Tocilizumab. Intern Med 2017; 56: 2353–60.</mixed-citation><mixed-citation xml:lang="ru">Sato H., Wada Y., Hasegawa E., Nozawa Y., Nakatsue T., Ito T., et al. Adult-onset Chronic Recurrent Multifocal Osteomyelitis with High Intensity of Muscles Detected by Magnetic Resonance Imaging, Successfully Controlled with Tocilizumab. Intern Med 2017; 56: 2353–60.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Giedion A., Holthusen W., Masel L.F., Vischer D. Subacute and chronic “symmetrical” osteomyelitis. Ann Radiol (Paris) 1972; 15: 329–2.</mixed-citation><mixed-citation xml:lang="ru">Giedion A., Holthusen W., Masel L.F., Vischer D. Subacute and chronic “symmetrical” osteomyelitis. Ann Radiol (Paris) 1972; 15: 329–2.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Hofmann S.R., Kapplusch F., Girschick H.J., Morbach H., Schnabel A., Rosen-Wolff A., et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment. Curr Osteoporos Rep 2017; 15: 542–54.</mixed-citation><mixed-citation xml:lang="ru">Hofmann S.R., Kapplusch F., Girschick H.J., Morbach H., Schnabel A., Rosen-Wolff A., et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment. Curr Osteoporos Rep 2017; 15: 542–54.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Копчак О.Л., Костик М.М., Мушкин А.Ю. Хронический небактериальный («стерильный») остеомиелит в практике детского ревматолога, современные подходы к диагностике и лечению: обзор литературы и анализ собственных данных. Вопросы современной педиатрии 2016; 15 (1): 33–44.</mixed-citation><mixed-citation xml:lang="ru">Копчак О.Л., Костик М.М., Мушкин А.Ю. Хронический небактериальный («стерильный») остеомиелит в практике детского ревматолога, современные подходы к диагностике и лечению: обзор литературы и анализ собственных данных. Вопросы современной педиатрии 2016; 15 (1): 33–44.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Valdearcos M., Esquinas E., Meana C., Pena L., Gil-de-Gomez L., Balsinde J., et al. Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. J Biol Chem 2012; 287: 10894–904.</mixed-citation><mixed-citation xml:lang="ru">Valdearcos M., Esquinas E., Meana C., Pena L., Gil-de-Gomez L., Balsinde J., et al. Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. J Biol Chem 2012; 287: 10894–904.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Ferguson P.J. Current Understating of the Pathogenesis and Management of Chronic Reccurent Multifocal Osteomyelitis. Curr Reumatol Rep 2012; 14 (2): 130–41.</mixed-citation><mixed-citation xml:lang="ru">Ferguson P.J. Current Understating of the Pathogenesis and Management of Chronic Reccurent Multifocal Osteomyelitis. Curr Reumatol Rep 2012; 14 (2): 130–41.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Herlin T., Fiirgaard B., Bjerre M., Kerndrup G., Hasle H., Bing X., et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis 2013; 72: 410–3.</mixed-citation><mixed-citation xml:lang="ru">Herlin T., Fiirgaard B., Bjerre M., Kerndrup G., Hasle H., Bing X., et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis 2013; 72: 410–3.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Omenetti A., Carta S., Caorsi R., Finetti M., Marotto D., Lattanzi B., et al. Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome. Rheumatology (Oxford) 2016;55:1325–35.</mixed-citation><mixed-citation xml:lang="ru">Omenetti A., Carta S., Caorsi R., Finetti M., Marotto D., Lattanzi B., et al. Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome. Rheumatology (Oxford) 2016;55:1325–35.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Holzinger D., Fassl S.K., de Jager W., Lohse P., Röhrig U.F., et al. Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)- associated inflammatory diseases. J Allergy Clin Immunol 2015; 136 (5): 1337–45.</mixed-citation><mixed-citation xml:lang="ru">Holzinger D., Fassl S.K., de Jager W., Lohse P., Röhrig U.F., et al. Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)- associated inflammatory diseases. J Allergy Clin Immunol 2015; 136 (5): 1337–45.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Yoshitaka T., Ishida S., Mukai T., Kittaka M., Reichenberger E.J., Ueki Y. Etanercept administration to neonatal SH3BP2 knock in cherubism mice prevents TNFinduced inflammation and bone loss. J Bone Miner Res 2014; 29 (5): 1170–82.</mixed-citation><mixed-citation xml:lang="ru">Yoshitaka T., Ishida S., Mukai T., Kittaka M., Reichenberger E.J., Ueki Y. Etanercept administration to neonatal SH3BP2 knock in cherubism mice prevents TNFinduced inflammation and bone loss. J Bone Miner Res 2014; 29 (5): 1170–82.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Ferguson P.J., El-Shanti H.I. Autoinflammatory bone disorders. Curr Opin Rheumatol 2007;19 (5): 492–8.</mixed-citation><mixed-citation xml:lang="ru">Ferguson P.J., El-Shanti H.I. Autoinflammatory bone disorders. Curr Opin Rheumatol 2007;19 (5): 492–8.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Shoham N.G., Centola M., Mansfield E., Hull K.M., Wood G., Wise C.A., Kastner D.L. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A 2003; 100 (23): 13501–6. DOI: 10.1073/ pnas.2135380100</mixed-citation><mixed-citation xml:lang="ru">Shoham N.G., Centola M., Mansfield E., Hull K.M., Wood G., Wise C.A., Kastner D.L. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A 2003; 100 (23): 13501–6. DOI: 10.1073/ pnas.2135380100</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Masters S.L., Simon A., Aksentijevich I., Kastner D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Ann Rev Immunol 2009; 27: 621–68. DOI: 10.1146/annurev.immunol.25.022106.141627</mixed-citation><mixed-citation xml:lang="ru">Masters S.L., Simon A., Aksentijevich I., Kastner D.L. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Ann Rev Immunol 2009; 27: 621–68. DOI: 10.1146/annurev.immunol.25.022106.141627</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Hedrich C.M., Hahn G., Girschick H.J., Morbach H. A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis and challenges facing the field. Expert Rev Clin Immunol 2013; 9 (9): 845–4. DOI: 10.1586/1744666X.2013.824670</mixed-citation><mixed-citation xml:lang="ru">Hedrich C.M., Hahn G., Girschick H.J., Morbach H. A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis and challenges facing the field. Expert Rev Clin Immunol 2013; 9 (9): 845–4. DOI: 10.1586/1744666X.2013.824670</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Khan M.A., Osborne N.J., Anaspure R., Ramanan A.V. Clavicular swelling-classic presentation of chronic non-bacterial osteomyelitis. Arch Dis Child 2012; 98: 238. DOI: 10.1136/archdischild-2012-303187</mixed-citation><mixed-citation xml:lang="ru">Khan M.A., Osborne N.J., Anaspure R., Ramanan A.V. Clavicular swelling-classic presentation of chronic non-bacterial osteomyelitis. Arch Dis Child 2012; 98: 238. DOI: 10.1136/archdischild-2012-303187</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Mandell G.A., Contreras S.J., Conard K., et al. Bone scintigraphy in the detection of chronic recurrent multifocal osteomyelitis. J Nucl Med. 1998;39:1778–3.</mixed-citation><mixed-citation xml:lang="ru">Mandell G.A., Contreras S.J., Conard K., et al. Bone scintigraphy in the detection of chronic recurrent multifocal osteomyelitis. J Nucl Med. 1998;39:1778–3.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Шаяхметова Р.У., Сигидин Я.А., Кузьмина Н.Н., Смирнов А.В. Хронический рецидивирующий мультифокальный остеомиелит в практике ревматолога (семейные наблюдения). Научно-практическая ревматология 2015; 53 (5): 568–72.</mixed-citation><mixed-citation xml:lang="ru">Шаяхметова Р.У., Сигидин Я.А., Кузьмина Н.Н., Смирнов А.В. Хронический рецидивирующий мультифокальный остеомиелит в практике ревматолога (семейные наблюдения). Научно-практическая ревматология 2015; 53 (5): 568–72.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Khanna G., Sato T.S., Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics 2009; 29: 1159–7.</mixed-citation><mixed-citation xml:lang="ru">Khanna G., Sato T.S., Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics 2009; 29: 1159–7.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Hofmann S.R., Kapplusch F., Girschick H.J., Morbach H., Pablik J., Ferguson P.J., et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment. Curr Osteoporos Rep (2017) 15:542–54.</mixed-citation><mixed-citation xml:lang="ru">Hofmann S.R., Kapplusch F., Girschick H.J., Morbach H., Pablik J., Ferguson P.J., et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment. Curr Osteoporos Rep (2017) 15:542–54.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Hamel J., Paul D., Gahr M., Hedrich C.M. Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol Int 2012; 32: 555–6.</mixed-citation><mixed-citation xml:lang="ru">Hamel J., Paul D., Gahr M., Hedrich C.M. Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol Int 2012; 32: 555–6.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Hofmann S.R., Kubasch A.S., Ioannidis C., Rosen-Wolff A., Girschick H.J., Morbach H., et al. Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1beta expression and release. Clin Immunol 2015; 161: 300–7.</mixed-citation><mixed-citation xml:lang="ru">Hofmann S.R., Kubasch A.S., Ioannidis C., Rosen-Wolff A., Girschick H.J., Morbach H., et al. Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1beta expression and release. Clin Immunol 2015; 161: 300–7.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25. Hofmann S.R., Morbach H., Schwarz T., Rosen-Wolff A., Girschick H.J., Hedrich C.M. Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 2012; 145: 69–76.</mixed-citation><mixed-citation xml:lang="ru">Hofmann S.R., Morbach H., Schwarz T., Rosen-Wolff A., Girschick H.J., Hedrich C.M. Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 2012; 145: 69–76.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26. Hofmann S.R., Schwarz T., Moller J.C., Morbach H., Schnabel A., Rosen-Wolff A., et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol 2011; 141: 317–27.</mixed-citation><mixed-citation xml:lang="ru">Hofmann S.R., Schwarz T., Moller J.C., Morbach H., Schnabel A., Rosen-Wolff A., et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol 2011; 141: 317–27.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27. Hofmann S.R., Morbach H., Schwarz T., Rosen-Wolff A., Girschick H.J., Hedrich C.M. Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 2012; 145: 69–76.</mixed-citation><mixed-citation xml:lang="ru">Hofmann S.R., Morbach H., Schwarz T., Rosen-Wolff A., Girschick H.J., Hedrich C.M. Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin Immunol 2012; 145: 69–76.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28. Hofmann S.R., Schwarz T., Moller J.C., Morbach H., Schnabel A., Rosen-Wolff A., et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol 2011; 141: 317–27.</mixed-citation><mixed-citation xml:lang="ru">Hofmann S.R., Schwarz T., Moller J.C., Morbach H., Schnabel A., Rosen-Wolff A., et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin Immunol 2011; 141: 317–27.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Hofmann S.R., Kapplusch F., Girschick H.J., Morbach H., Pablik J., Ferguson P.J., et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment. Curr Osteoporos Rep 2017; 15: 542–54.</mixed-citation><mixed-citation xml:lang="ru">Hofmann S.R., Kapplusch F., Girschick H.J., Morbach H., Pablik J., Ferguson P.J., et al. Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment. Curr Osteoporos Rep 2017; 15: 542–54.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30. Valdearcos M., Esquinas E., Meana C., Pena L., Gil-de-Gomez L., Balsinde J., et al. Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. J Biol Chem 2012; 287: 10894–904.</mixed-citation><mixed-citation xml:lang="ru">Valdearcos M., Esquinas E., Meana C., Pena L., Gil-de-Gomez L., Balsinde J., et al. Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. J Biol Chem 2012; 287: 10894–904.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31. Ferguson PJ. Current Understating of the Pathogenesis and Management of Chronic Reccurent Multifocal Osteomyelitis. Curr Reumatol Rep 2012; 14 (2): 130–41.</mixed-citation><mixed-citation xml:lang="ru">Ferguson PJ. Current Understating of the Pathogenesis and Management of Chronic Reccurent Multifocal Osteomyelitis. Curr Reumatol Rep 2012; 14 (2): 130–41.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32. Herlin T., Fiirgaard B., Bjerre M., Kerndrup G., Hasle H., Bing X., et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis 2013; 72: 410–3.</mixed-citation><mixed-citation xml:lang="ru">Herlin T., Fiirgaard B., Bjerre M., Kerndrup G., Hasle H., Bing X., et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis 2013; 72: 410–3.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">33. Jansson A., Renner E.D., Ramer J., Haban M., Meindl A., Grote V. et al. Classification of nonbacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007; 46: 154–60.</mixed-citation><mixed-citation xml:lang="ru">Jansson A., Renner E.D., Ramer J., Haban M., Meindl A., Grote V. et al. Classification of nonbacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 2007; 46: 154–60.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">34. Pastore S., Ferrara G., Monasta L., Meini A., Cattalini M., Martino S., et al. Chronic nonbacterial osteomyelitis may be associated with renal disease and bisphosphonates are a good option for the majority of patients. Acta Paediatr 2016; 105 (7): e328–33. DOI: 10.1111/apa.13420</mixed-citation><mixed-citation xml:lang="ru">Pastore S., Ferrara G., Monasta L., Meini A., Cattalini M., Martino S., et al. Chronic nonbacterial osteomyelitis may be associated with renal disease and bisphosphonates are a good option for the majority of patients. Acta Paediatr 2016; 105 (7): e328–33. DOI: 10.1111/apa.13420</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">35. Catalano-Pons C., Comte A., Wipff J., Quartier P., Faye A., Gendrel D., et al. Clinical outcome in children with chronic recurrent multifocal osteomyelitis. Rheumatology 2008; 47: 1397–9.</mixed-citation><mixed-citation xml:lang="ru">Catalano-Pons C., Comte A., Wipff J., Quartier P., Faye A., Gendrel D., et al. Clinical outcome in children with chronic recurrent multifocal osteomyelitis. Rheumatology 2008; 47: 1397–9.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">36. Teixeira S.R., Elias Junior J., Nogueira-Barbosa M.H., Guimaraes M.D., Marchiori E., Santos M.K. Whole body magnetic resonance imaging in children: state of the art. Radiol Bras 2015; 48 (2): 111–20.</mixed-citation><mixed-citation xml:lang="ru">Teixeira S.R., Elias Junior J., Nogueira-Barbosa M.H., Guimaraes M.D., Marchiori E., Santos M.K. Whole body magnetic resonance imaging in children: state of the art. Radiol Bras 2015; 48 (2): 111–20.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">37. Colmenero J.D., Ruiz-Mesa J.D., Sanjuan-Simenez R., Sobrino B., Morata P. Establishing the diagnosis of tuberculosus vertebral osteomyelitis. Eur spine J 2013; 22 (suppl 4): S579–86</mixed-citation><mixed-citation xml:lang="ru">Colmenero J.D., Ruiz-Mesa J.D., Sanjuan-Simenez R., Sobrino B., Morata P. Establishing the diagnosis of tuberculosus vertebral osteomyelitis. Eur spine J 2013; 22 (suppl 4): S579–86</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">38. Girschick H.J., Zimmer C., Klaus G., Darge K., Dick A., Morbach H. Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated? Nat Clin Pract Rheumatol 2007; 3 (12): 733–8.</mixed-citation><mixed-citation xml:lang="ru">Girschick H.J., Zimmer C., Klaus G., Darge K., Dick A., Morbach H. Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated? Nat Clin Pract Rheumatol 2007; 3 (12): 733–8.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">39. Santra G., Sarkar R.N., Phaujdar S., Banerjee S., Siddhanta S. Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial. Singapore Med J 2010; 51 (11): 883–7.</mixed-citation><mixed-citation xml:lang="ru">Santra G., Sarkar R.N., Phaujdar S., Banerjee S., Siddhanta S. Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial. Singapore Med J 2010; 51 (11): 883–7.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">40. Zhao Y., Wu E., Oliver M., Cooper A., Basiaga M.L., Vora S.S., et al. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or with Active Spinal Lesions. Arthritis Care Res (Hoboken) 2018; 70 (8): 1228–37. DOI: 10.1002/acr.23462</mixed-citation><mixed-citation xml:lang="ru">Zhao Y., Wu E., Oliver M., Cooper A., Basiaga M.L., Vora S.S., et al. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or with Active Spinal Lesions. Arthritis Care Res (Hoboken) 2018; 70 (8): 1228–37. DOI: 10.1002/acr.23462</mixed-citation></citation-alternatives></ref></ref-list></back></article>
